UPDATE: Kura Oncology (KURA) Tops Q1 EPS by 1c; Expands Enrollment in Phase 2 Trial of Tipifarnib

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. GOOGL
6. APGE
7. DFTX
8. MU
9. IBM
10. HOOD

Go back to UPDATE: Kura Oncology (KURA) Tops Q1 EPS by 1c; Expands Enrollment in Phase 2 Trial of Tipifarnib
(NASDAQ: KURA) Delayed: 10.36 +0.43 (4.33%)
Previous Close $9.93    52 Week High $8.90 
Open $9.96    52 Week Low $2.50 
Day High $10.54    P/E N/A 
Day Low $9.95    EPS $0.00 
Volume 1,383,616